Related references
Note: Only part of the references are listed.CD122+CD8+ Treg suppress vaccine-induced antitumor immune responses in lymphodepleted mice
Li-Xin Wang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art
Taylor H. Schreiber et al.
SEMINARS IN IMMUNOLOGY (2010)
Memory and cellular immunity induced by a DNA vaccine encoding self antigen TPD52 administered with soluble GM-CSF
Jennifer D. Lewis et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Overlapping synthetic peptides encoding TPD52 as breast cancer vaccine in mice: Prolonged survival
Saied Mirshahidi et al.
VACCINE (2009)
Systemic targeting of CpG-ODN to the tumor microenvironment with anti-neu-CpG hybrid molecule and T regulatory cell depletion induces memory responses in BALB-neuT tolerant mice
Sanjay Sharma et al.
CANCER RESEARCH (2008)
Balancing between Antitumor Efficacy and Autoimmune Pathology in T-Cell-Mediated Targeting of Carcinoembryonic Antigen
Rinke Bos et al.
CANCER RESEARCH (2008)
Generation and Regulation of CD8+ Regulatory T Cells
Linrong Lu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2008)
Expression of chloride intracellular channel protein 1 (CLIC1) and tumor protein D52 (TPD52) as potential biomarkers for colorectal cancer
Darinka Todorova Petrova et al.
CLINICAL BIOCHEMISTRY (2008)
Nonredundant functions for tumor protein D52-like proteins support specific targeting of TPD52
Mona Shehata et al.
CLINICAL CANCER RESEARCH (2008)
Telomerase as a universal tumor antigen for cancer vaccines
Gregory L. Beatty et al.
EXPERT REVIEW OF VACCINES (2008)
Are CD8+CD122+ cells regulatory T cells or memory T cells?
Haruhiko Suzuki et al.
HUMAN IMMUNOLOGY (2008)
Murine CD8+ regulatory T lymphocytes: The new era
Celine Pomie et al.
HUMAN IMMUNOLOGY (2008)
Human CD4 and CD8 regulatory T cells in infectious diseases and vaccination
Simone A. Joosten et al.
HUMAN IMMUNOLOGY (2008)
CD8+ regulatory T cells, their suppressive mechanisms, and regulation in cancer
Rong-Fu Wang
HUMAN IMMUNOLOGY (2008)
Advancements on phenotypic and functional characterization of non-antigen-specific CD8+CD28-regulatory T cells
Daniela Fenoglio et al.
HUMAN IMMUNOLOGY (2008)
Location and time-dependent control of rejection by regulatory T cells culminates in a failure to generate memory T cells
Manuela Carvalho-Gaspar et al.
JOURNAL OF IMMUNOLOGY (2008)
Vaccination with metastasis-related tumor associated antigen TPD52 and CpG/ODN induces protective tumor immunity
Laura A. Payton et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Transforming growth factor β-producing Foxp3+CD8+CD25+ T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions
Sunao Sugita et al.
EXPERIMENTAL EYE RESEARCH (2007)
The universal character of the tumour-associated antigen survivin
Mads Hald Andersen et al.
CLINICAL CANCER RESEARCH (2007)
Opinion - Are oncoantigens suitable targets for anti-tumour therapy?
Federica Cavallo et al.
NATURE REVIEWS CANCER (2007)
Induction of tumorigenesis and metastasis by the murine orthologue of tumor protein D52
Jennifer D. Lewis et al.
MOLECULAR CANCER RESEARCH (2007)
Preclinical and clinical studies of recombinant poxvirus Vaccines for carcinoma therapy
Philip M. Arlen et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2007)
A testis-specific and testis developmentally regulated tumor protein D52 (TPD52)-like protein TPD52L3/hD55 interacts with TPD52 family proteins
Qinhong Cao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Tumor protein D52 (TPD52) is overexpressed and a gene amplification target in ovarian cancer
JA Byrne et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
In vivo depletion of CD4+CD25+ regulatory T cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells
S Van Meirvenne et al.
MOLECULAR THERAPY (2005)
Interleukin-10 and the immune response against cancer: a counterpoint
S Mocellin et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
MUC1 as a target antigen for cancer immunotherapy
B Acres et al.
EXPERT REVIEW OF VACCINES (2005)
Tumor protein D52 (TPD52):: a novel B-cell/plasma-cell molecule with unique expression pattern and Ca2+-dependent association with annexin VI
E Tiacci et al.
BLOOD (2005)
Surrogate tumor antigen vaccination induces tumor-specific immunity and the rejection of spontaneous metastases
JD Lewis et al.
CANCER RESEARCH (2005)
PrLZ, a novel prostate-specific and androgen-responsive gene of the TPD52 family, amplified in chromosome 8q21.1 and overexpressed in human prostate cancer
RX Wang et al.
CANCER RESEARCH (2004)
Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer
MA Rubin et al.
CANCER RESEARCH (2004)
Identification of Src transformation fingerprint in human colon cancer
RL Malek et al.
ONCOGENE (2002)
SV40 Tag-specific cytotoxic T lymphocytes generated from the peripheral blood of malignant pleural mesothelioma patients
RK Bright et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2002)
Delineation of prognostic biomarkers in prostate cancer
SM Dhanasekaran et al.
NATURE (2001)
Share Paper
